Effect of Smoking and Periodontal Therapy on Salivary and Gingival Crevicular IL-17 and IL-35
Launched by GAZI UNIVERSITY · Mar 15, 2022
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
Periodontal diseases are among the complex inflammatory diseases that are considered among the leading causes of tooth loss, mostly observed with multiple etiological factors. The complexity of periodontal disease is due to the presence of the biofilm and the accompanying host response together.
Smoking, which is considered as one of the risk factors in terms of periodontitis, is one of the most preventable risk factors that affect the periodonium with many different mechanisms. Smoking plays a role in the etiopathogenesis of periodontitis, with its physiological changes in gingival tissue...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • To be volunteer to participate in the study
- • To be over 18
- • Being systemically healthy
- • Having greater than or equal to 15 teeth out of 3rd molar teeth
- • To have localized or generalized periodontitis for the experimental group (clinical attachment loss in at least 6 surrounding areas and presence of greater than or equal to 5 mm periodontal pocket)
- • For Smoking group; more than 10 cigarettes a day for more than 5 years
- • For non-smokers; have not smoked for at least 3 years.
- Exclusion Criteria:
- • Have any systemic disease affecting periodontal condition
- • To receive periodontal treatment in the last 6 months
- • Use any medication that may affect the inflammatory process in the last 3 months
- • Use local or systemic antibiotics in the last 3 months
- • Pregnancy or lactation for female patients
- • Regular use of mouthwash
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Gülay Tüter, Professor
Study Director
Gazi University Dentistry Faculty Department of Periodontology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials